shenzhen salubris pharmaceuticals co., ltd.-九游会

clinical research on sal007 in usa


sal007 was approved by fda in february 2020 for its first clinical trial. the head clinical researchinstitute of clinical phase i in us is cleveland clinic, and currently thetrial is recruiting participants. the participants have achieved very good results.

sal007 phase i clinical research center